Literature DB >> 35996590

Science and beyond science in the reporting of quality of facility-based maternal and newborn care during the COVID-19 pandemic-Authors' reply.

Marzia Lazzerini1, Raquel Costa2,3,4, Ilaria Mariani1, Eline Skirnisdottir Vik5, Helen Elden6,7, Karolina Linden6, Mehreen Zaigham8, Alina Liepinaitienė9, Maryse Arendt10, Zalka Drglin11, Emma Sacks12, Ornella Lincetto1, Emanuelle Pessa Valente1.   

Abstract

Entities:  

Year:  2022        PMID: 35996590      PMCID: PMC9386305          DOI: 10.1016/j.lanepe.2022.100488

Source DB:  PubMed          Journal:  Lancet Reg Health Eur        ISSN: 2666-7762


× No keyword cloud information.
In their correspondence, Bernardes et al. underscore discrepancies between a few results of the IMAgiNE EURO survey related to Portugal and the national statistics or other surveillance systems. However, data are not directly comparable. IMAgiNE EURO collected information from mothers giving birth in both private and public facilities, during a specific time frame (i.e., the first year of the COVID-19 pandemic), while the other two datasets referred to by Bernardes et al. either covered a different time period or population (Table 1). Additionally, differences in findings for C-section (with 95% confidence intervals almost overlapping) and instrumental vaginal births (4·9% percent difference among databases) do not seem substantial.
Table 1

Evidence from different datasets reporting on key indicators from Portugal during the COVID-19 pandemic.

IMAgiNE EURO (Portugal)1INE2CPDO3
Time periodMar 2020 – Mar 2021Jan 2020 – Dec 2020Mar 2020 – Mar 2021
Regions of PortugalAll regionsNationwideNorth, Centre, and Lisbon Metropolitan Area
Type of facilitiesPrivate and publicPrivate and publicPublic
Total number of birthsN = 1,685N = 83,873N = 23,368
n%95%CIn%95%CIn%95%CI
C-sections57334·031·7–36·330,41236·335·9–36·67,14030·630·0–31·1
IVB40023·721·7–25·815,80718·818·6–19·14,91021·020·5–21·5
Episiotomy rate in non-IVB4290/71240·737·1–44·3NA3,539/ 11,31831·330·4–32·1

Abbreviations: CI: confidence intervals; CPDO = Consórcio Português de Dados Obstétricos, Portugal; INE= Instituto Nacional de Estatística, Portugal; IVB: instrumental vaginal births; NA = not available.

Notes: 1Lazzerini M et all Lancet Reg Health Eur 2022;13:100268; 2Instituto Nacional de Estatística – Statistics Portugal. Available https://www.ine.pt/xportal/xmain?xpgid=ine_main&xpid=INE&xlang=; 3Consórcio Português de Dados Obstétricos (CPDO). Available at: https://cpdo.virtualcare.pt/. Accessed 5 July 2020; 4Frequency of episiotomy and number of non-IVB (n/N) was reported.

Evidence from different datasets reporting on key indicators from Portugal during the COVID-19 pandemic. Abbreviations: CI: confidence intervals; CPDO = Consórcio Português de Dados Obstétricos, Portugal; INE= Instituto Nacional de Estatística, Portugal; IVB: instrumental vaginal births; NA = not available. Notes: 1Lazzerini M et all Lancet Reg Health Eur 2022;13:100268; 2Instituto Nacional de Estatística – Statistics Portugal. Available https://www.ine.pt/xportal/xmain?xpgid=ine_main&xpid=INE&xlang=; 3Consórcio Português de Dados Obstétricos (CPDO). Available at: https://cpdo.virtualcare.pt/. Accessed 5 July 2020; 4Frequency of episiotomy and number of non-IVB (n/N) was reported. Bernardes et al. also expressed their disappointment towards how data were reported by media. It seems that Portuguese media focused on a minor part of the published paper, taken out of its context and not fully discussed. Misinterpretation and partial reporting by media is a well-known phenomenon; however, how the media chooses to report research is beyond our control. We do not believe that this should refrain researchers from publishing their data. The IMAgiNE EURO survey made available substantial amounts of information. Specifically, the IMAgiNE EURO Project collect 80 Quality Measures based on WHO Standards, which have been developed by a group of 116 experts from 46 countries. Most Quality Measures, such as those on “experience of care” and “availability of resources” are currently missing from most national statistics. These findings complement existing national statistics, by providing new evidence. Most importantly, this new evidence can be used constructively to improve quality of care for mothers, newborns, health professionals, and the entire community. Further, with the objective of having a comprehensive perspective, the IMAgiNE EURO Project deliberately included two complementary data sources: the perspectives of mothers, and the perspectives of health professionals (results forthcoming). We agree that adding additional questions to the information already collected by the IMAgiNE EURO surveys – currently 80 Quality Measures and 20 socio-demographic variables – may be useful, especially to enhance data on the responders’ clinical characteristics, however this needs to be balanced with appropriateness of data sources, privacy, and survey length from responders. From the methodological side, several measures were adopted to reduce the risk of bias in the IMAgiNE EURO surveys. These included: the questionnaires were formally validated for content, construct, face validity, intra-rater reliability, and internal consistency, and were field tested to verify acceptability and utility,; translation and back-translation was conducted in 25 languages; data were cleaned according to predefined procedures; multivariate and sensitivity analyses were conducted. On average, routinely collected data are protected by many fewer quality assurance measures. As such, new evidence generated by IMAgiNE EURO is valuable. Several published, and upcoming papers from the IMAgiNE EURO Project are reporting heterogeneous quality of care across countries and across regions in the same country. However, data comparisons across countries or regions should be used constructively and proactively, aiming at improving quality of care. IMAgiNE EURO findings can be used at different levels of the health system including by health authorities to identify needs for additional resources for the health systems; by scientific societies to identify needs for clinical protocols/training, and by health professionals to improve their own practices – such as improving communication with mothers or adjusting the clinical environment to improve privacy and other aspects in experience of care. IMAgiNE EURO is strongly committed to work toward better quality of care for the whole community in an inclusive manner. The research network is multidisciplinary, including many different types of professionals: physicians, midwives, breastfeeding consultants, public health specialists, anthropologists, women's rights advocates, and mothers. We actively welcome partnership with any professional and scientific societies, research units, or individuals genuinely committed to improving the quality of care for mothers and newborns around the time of childbirth. The IMAgiNE EURO Network currently includes 31 institutions in 20 WHO European countries and has so far collected the opinions of more than 50,000 women and 4,000 health professionals. The study network and results are continuously growing, reflecting the strong motivation by health professionals to improve quality of care, and the importance of this topic to women.

Contributors

ML wrote the first draft, with major inputs from all authors. All authors have approved the final version of the manuscript for submission.

Declaration of interests

ES has no commercial contracts. She has received research funding from WHO, UNICEF, and USAID for work related to quality of maternal and pediatric care. All other authors have none to declare.
  5 in total

1.  WHO Standards-based questionnaire to measure health workers' perspective on the quality of care around the time of childbirth in the WHO European region: development and mixed-methods validation in six countries.

Authors:  Emanuelle Pessa Valente; Benedetta Covi; Ilaria Mariani; Sandra Morano; Marina Otalea; Ioana Nanu; Micaela Iuliana Nanu; Helen Elden; Karolina Linden; Mehreen Zaigham; Eline Skirnisdottir Vik; Sigrun Kongslien; Ingvild Nedberg; Raquel Costa; Carina Rodrigues; Heloísa Dias; Daniela Drandić; Magdalena Kurbanović; Emma Sacks; Moise Muzigaba; Ornella Lincetto; Marzia Lazzerini
Journal:  BMJ Open       Date:  2022-04-08       Impact factor: 2.692

2.  WHO standards-based tool to measure women's views on the quality of care around the time of childbirth at facility level in the WHO European region: development and validation in Italy.

Authors:  Marzia Lazzerini; Giorgia Argentini; Ilaria Mariani; Benedetta Covi; Chiara Semenzato; O Lincetto; Moise Muzigaba; Emanuelle Pessa Valente
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 2.692

3.  Quality of facility-based maternal and newborn care around the time of childbirth during the COVID-19 pandemic: online survey investigating maternal perspectives in 12 countries of the WHO European Region.

Authors:  Marzia Lazzerini; Benedetta Covi; Ilaria Mariani; Zalka Drglin; Maryse Arendt; Ingvild Hersoug Nedberg; Helen Elden; Raquel Costa; Daniela Drandić; Jelena Radetić; Marina Ruxandra Otelea; Céline Miani; Serena Brigidi; Virginie Rozée; Barbara Mihevc Ponikvar; Barbara Tasch; Sigrun Kongslien; Karolina Linden; Catarina Barata; Magdalena Kurbanović; Jovana Ružičić; Stephanie Batram-Zantvoort; Lara Martín Castañeda; Elise de La Rochebrochard; Anja Bohinec; Eline Skirnisdottir Vik; Mehreen Zaigham; Teresa Santos; Lisa Wandschneider; Ana Canales Viver; Amira Ćerimagić; Emma Sacks; Emanuelle Pessa Valente
Journal:  Lancet Reg Health Eur       Date:  2021-12-24

4.  Quality of care at childbirth: Findings of IMAgiNE EURO in Italy during the first year of the COVID-19 pandemic.

Authors:  Marzia Lazzerini; Benedetta Covi; Ilaria Mariani; Angela Giusti; Emanuelle Pessa Valente
Journal:  Int J Gynaecol Obstet       Date:  2022-02-20       Impact factor: 3.561

5.  Science and beyond science in the reporting of quality of facility-based maternal and newborn care during the COVID-19 pandemic.

Authors:  J Bernardes; A Reynolds
Journal:  Lancet Reg Health Eur       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.